Cargando…

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV

Chronic hepatitis B virus (HBV) infection affects 257 million people globally. Current therapies suppress HBV but viral rebound occurs on cessation of therapy; novel therapeutic strategies are urgently required. To develop a therapeutic HBV vaccine that can induce high magnitude T cells to all major...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinnakannan, Senthil K., Cargill, Tamsin N., Donnison, Timothy A., Ansari, M. Azim, Sebastian, Sarah, Lee, Lian Ni, Hutchings, Claire, Klenerman, Paul, Maini, Mala K., Evans, Tom, Barnes, Eleanor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348829/ https://www.ncbi.nlm.nih.gov/pubmed/32295168 http://dx.doi.org/10.3390/vaccines8020184

Ejemplares similares

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
por: Cargill, Tamsin, et al.
Publicado: (2023)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
por: von Delft, Annette, et al.
Publicado: (2018)

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
por: Capone, Stefania, et al.
Publicado: (2020)

Divergent memory responses driven by adenoviral vectors are impacted by epitope competition
por: Colston, Julia M, et al.
Publicado: (2019)

A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
por: Donnison, Timothy, et al.
Publicado: (2022)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

T cell receptor-therapy in HBV-related hepatocellularcarcinoma
por: Bertoletti, Antonio, et al.
Publicado: (2015)

Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
por: Gill, Upkar S, et al.
Publicado: (2018)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
por: Stylianou, E., et al.
Publicado: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Humic acid inhibits HBV-induced autophagosome formation and induces apoptosis in HBV-transfected Hep G2 cells
por: Pant, Kishor, et al.
Publicado: (2016)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage
por: Lehmann, Michael H, et al.
Publicado: (2015)

Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting
por: Chuai, Xia, et al.
Publicado: (2013)

Purification of modified vaccinia virus Ankara from suspension cell culture
por: Jordan, Ingo, et al.
Publicado: (2015)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
por: Jordan, Ingo, et al.
Publicado: (2013)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
por: Orlova, Olga Vladimirovna, et al.
Publicado: (2022)

Modified vaccinia Ankara–Bavarian Nordic vaccine against mpox in children
por: Turtle, Lance, et al.
Publicado: (2023)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
por: Downs, Louise O., et al.
Publicado: (2021)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01(B) With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
por: Rampling, Tommy, et al.
Publicado: (2016)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
por: Préville, Xavier, et al.
Publicado: (2015)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
por: Okeke, Malachy I., et al.
Publicado: (2017)

A vital gene for modified vaccinia virus Ankara replication in human cells
por: Sutter, Gerd
Publicado: (2020)

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
por: Czub, Markus, et al.
Publicado: (2005)

Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara
por: Jordan, Ingo, et al.
Publicado: (2009)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015)

Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans
por: Chen, Zhaochun, et al.
Publicado: (2020)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
por: McNaughton, Anna L., et al.
Publicado: (2019)

Defective natural killer cell anti-viral capacity in paediatric HBV infection
por: Heiberg, I L, et al.
Publicado: (2015)

The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
por: Schurich, Anna, et al.
Publicado: (2013)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9r0j2cbltf1jk8gg5quojabmje